Towards consistency between guidelines and policy: Lipid Management - 2005

Heart Lung and Circulation

Volumn 14, Issue 4, 2005, Pages 237-238

  Tonkin, Andrew M ^a  

^a NATIONAL HEART FOUNDATION OF AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERY DISEASE; ATHEROSCLEROSIS; AUSTRALIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG COST; EDITORIAL; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MEDICAL SOCIETY; META ANALYSIS; NEW ZEALAND; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; RISK REDUCTION;

EID: 30344462668     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2005.10.009     Document Type: Editorial

References (9)

1. The Shifting Burden of Cardiovascular Disease in Australia. Report by Access Economics Pty Limited 2005. Available at http://www.heartfoundation.com.au/media/nhfa_shifting_burden_cvd_0505.pdf Accessed 4 October 2005.
2. Pharmaceutical Pricing Section Pharmaceutical Benefits Branch. Expenditure and prescriptions twelve months to 30 June 2004. Available at http://www.health.gov.au/internet/wcms/publishing.nsf/Content/ health-pbs-general-pubs-pbbexp-jun04.htm.f Accessed 5 October 2005.
3. Australian Institute of Health & Welfare (AIHW) 2004. Heart, stroke and vascular diseases - Australian facts 2004. AIHW Cat. No. CVD 27. Canberra: AIHW and National Heart Foundation of Australia (Cardiovascular Disease Series No. 29).
4. Jackson RT. Are the new lipid management guidelines good for Australia's health? Med J Aust 2001;175:452-3.
5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
6. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-8.
7. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet. Published online September 27, 2005.
8. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2003;361:2005-16.
9. Britt H, Miller GC, Knox S, Charles J, Valenti L, Pan Y, et al. General Practice Activity in Australia 2003-04. AIHW Cat. No. GEP 16. Canberra: Australian Institute of Health and Welfare (General practice Series No. 16); 2004.